Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin.

Wang X, Andreassen PR, D'Andrea AD.

Mol Cell Biol. 2004 Jul;24(13):5850-62.

2.

The DNA crosslink-induced S-phase checkpoint depends on ATR-CHK1 and ATR-NBS1-FANCD2 pathways.

Pichierri P, Rosselli F.

EMBO J. 2004 Mar 10;23(5):1178-87. Epub 2004 Feb 26.

3.

Stabilization of stalled DNA replication forks by the BRCA2 breast cancer susceptibility protein.

Lomonosov M, Anand S, Sangrithi M, Davies R, Venkitaraman AR.

Genes Dev. 2003 Dec 15;17(24):3017-22. Epub 2003 Dec 17.

5.

A novel ubiquitin ligase is deficient in Fanconi anemia.

Meetei AR, de Winter JP, Medhurst AL, Wallisch M, Waisfisz Q, van de Vrugt HJ, Oostra AB, Yan Z, Ling C, Bishop CE, Hoatlin ME, Joenje H, Wang W.

Nat Genet. 2003 Oct;35(2):165-70. Epub 2003 Sep 14.

PMID:
12973351
6.

siRNA depletion of BRCA1, but not BRCA2, causes increased genome instability in Fanconi anemia cells.

Bruun D, Folias A, Akkari Y, Cox Y, Olson S, Moses R.

DNA Repair (Amst). 2003 Sep 18;2(9):1007-13.

PMID:
12967657
7.

Inhibition of cisplatin-induced ATR activity and enhanced sensitivity to cisplatin.

Yazlovitskaya EM, Persons DL.

Anticancer Res. 2003 May-Jun;23(3B):2275-9.

PMID:
12894503
8.

Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes.

Zou L, Elledge SJ.

Science. 2003 Jun 6;300(5625):1542-8.

9.

A central role for DNA replication forks in checkpoint activation and response.

Tercero JA, Longhese MP, Diffley JF.

Mol Cell. 2003 May;11(5):1323-36.

10.

T-cell clonality and myelodysplasia without chromosomal fragility in a patient with features of Seckel syndrome.

Chanan-Khan A, Holkova B, Perle MA, Reich E, Wu CD, Inghirami G, Takeshita K.

Haematologica. 2003 May;88(5):ECR14.

11.

A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome.

Meetei AR, Sechi S, Wallisch M, Yang D, Young MK, Joenje H, Hoatlin ME, Wang W.

Mol Cell Biol. 2003 May;23(10):3417-26.

12.

A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome.

O'Driscoll M, Ruiz-Perez VL, Woods CG, Jeggo PA, Goodship JA.

Nat Genet. 2003 Apr;33(4):497-501. Epub 2003 Mar 17.

PMID:
12640452
13.

ATR regulates fragile site stability.

Casper AM, Nghiem P, Arlt MF, Glover TW.

Cell. 2002 Dec 13;111(6):779-89.

14.

The Fanconi anaemia/BRCA pathway.

D'Andrea AD, Grompe M.

Nat Rev Cancer. 2003 Jan;3(1):23-34. Review.

PMID:
12509764
15.

Interaction of FANCD2 and NBS1 in the DNA damage response.

Nakanishi K, Taniguchi T, Ranganathan V, New HV, Moreau LA, Stotsky M, Mathew CG, Kastan MB, Weaver DT, D'Andrea AD.

Nat Cell Biol. 2002 Dec;4(12):913-20.

PMID:
12447395
16.

Checking on the fork: the DNA-replication stress-response pathway.

Osborn AJ, Elledge SJ, Zou L.

Trends Cell Biol. 2002 Nov;12(11):509-16. Review.

PMID:
12446112
17.

S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51.

Taniguchi T, Garcia-Higuera I, Andreassen PR, Gregory RC, Grompe M, D'Andrea AD.

Blood. 2002 Oct 1;100(7):2414-20.

18.

A requirement for replication in activation of the ATR-dependent DNA damage checkpoint.

Lupardus PJ, Byun T, Yee MC, Hekmat-Nejad M, Cimprich KA.

Genes Dev. 2002 Sep 15;16(18):2327-32.

19.

Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways.

Taniguchi T, Garcia-Higuera I, Xu B, Andreassen PR, Gregory RC, Kim ST, Lane WS, Kastan MB, D'Andrea AD.

Cell. 2002 May 17;109(4):459-72.

20.

Cell cycle checkpoint signaling through the ATM and ATR kinases.

Abraham RT.

Genes Dev. 2001 Sep 1;15(17):2177-96. Review. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk